Publications by authors named "Roberto Visentin"

Claim this Profile
S
Smart Algorithms for Efficient Insulin Therapy Initiation in Individuals With Type 2 Diabetes: An in Silico Study.
Jacopo Bonet, Roberto Visentin, Chiara Dalla Man

J Diabetes Sci Technol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doxorubicin PK/PD modeling in multiple myeloma: towards in silico trials.
Daniele Andrean, Francesco Da Ros, Mario Mazzucato, Morten Gram Pedersen, Roberto Visentin

Biol Direct· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring the Padova Type 2 Diabetes Simulator for Treatment Guidance in Target Populations.
Roberto Visentin, Michele Schiavon, Jacopo Bonet, Michela Riz, Britta Wagenhuber

IEEE Trans Biomed Eng· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Doxorubicin Pharmacokinetics in Multiple Myeloma Suggests Mechanism of Drug Resistance.
Roya Doshmanziari, Francesco Da Ros, Mario Mazzucato, Morten Gram Pedersen, Roberto Visentin

IEEE Trans Biomed Eng· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short- and Long-Term Effects on Glucose Control of Nonadherence to Insulin Therapy in People With Type 2 Diabetes An Study.
Roberto Visentin, Claudio Cobelli, Jochen Sieber, Chiara Dalla Man

J Diabetes Sci Technol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Insulin Secretion and Glucose Effectiveness in Obese Patients with Type 2 Diabetes following Bariatric Surgery.
Roberto Visentin, Katrine Brodersen, Bjørn Richelsen, Niels Møller, Chiara Dalla Man

J Diabetes Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A software interface for in silico testing of type 2 diabetes treatments.
Roberto Visentin, Claudio Cobelli, Chiara Dalla Man

Comput Methods Programs Biomed· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Recent Advances in Computer Simulation for Diabetes Treatment and Care.
Patricio Colmegna, Chiara Toffanin, Marzia Cescon, Roberto Visentin

Front Endocrinol (Lausanne)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Method for Generation of In Silico Subjects with Type 2 Diabetes.
Roberto Visentin, Mattia De Lazzari

Annu Int Conf IEEE Eng Med Biol Soc· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Pharmacokinetics of Doxorubicin in Multiple Myeloma Cells.
Alberto Giaretta, Francesco Da Ros, Mario Mazzucato, Morten Gram Pedersen, Roberto Visentin

Annu Int Conf IEEE Eng Med Biol Soc· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon-like peptide-1/glucagon receptor agonist SAR425899 in comparison with liraglutide.
Michele Schiavon, Roberto Visentin, Britta Göbel, Michela Riz, Claudio Cobelli

Diabetes Obes Metab· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of hepatic insulin clearance - Results from a Mendelian Randomization study.
Apostolia Lamprinou, Caroline Willmann, Jürgen Machann, Fritz Schick, Sabine S Eckstein, Roberto Visentin

Metabolism· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Padova Type 2 Diabetes Simulator from Triple-Tracer Single-Meal Studies: Trials Also Possible in Rare but Not-So-Rare Individuals.
Roberto Visentin, Claudio Cobelli, Chiara Dalla Man

Diabetes Technol Ther· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Head-to-Head Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL in Type 1 Diabetes.
Michele Schiavon, Roberto Visentin, Clemens Giegerich, Jochen Sieber, Chiara Dalla Man

Diabetes Technol Ther· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Silico Cloning of Target Type 2 Diabetes Population for Treatments Development and Decision Support.
Roberto Visentin, Michele Schiavon, Chiara Dalla Man

Annu Int Conf IEEE Eng Med Biol Soc· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual glucagon-like peptide-1 receptor/glucagon receptor agonist SAR425899 improves beta-cell function in type 2 diabetes.
Roberto Visentin, Michele Schiavon, Britta Göbel, Michela Riz, Claudio Cobelli

Diabetes Obes Metab· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes.
Michele Schiavon, Roberto Visentin, Clemens Giegerich, Thomas Klabunde, Claudio Cobelli

IEEE Trans Biomed Eng· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of hyperinsulinaemia in apparently healthy non-obese young adults: role of insulin secretion, clearance and action and associations with plasma amino acids.
Steven Hamley, Danielle Kloosterman, Tamara Duthie, Chiara Dalla Man, Roberto Visentin

Diabetologia· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating Long-Acting Insulin Glargine Into the UVA/Padova Type 1 Diabetes Simulator for In Silico Testing of MDI Therapies.
Roberto Visentin, Michele Schiavon, Clemens Giegerich, Thomas Klabunde, Chiara Dalla Man

IEEE Trans Biomed Eng· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Model of Acetaminophen Pharmacokinetics and its Effect on Continuous Glucose Monitoring Sensor Measurements.
Michele Schiavon, Giada Acciaroli, Martina Vettoretti, Alberto Giaretta, Roberto Visentin

Annu Int Conf IEEE Eng Med Biol Soc· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator.
Roberto Visentin, Michele Schiavon, Clemens Giegerich, Thomas Klabunde, Chiara Dalla Man

Annu Int Conf IEEE Eng Med Biol Soc· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day.
Roberto Visentin, Enrique Campos-Náñez, Michele Schiavon, Dayu Lv, Martina Vettoretti

J Diabetes Sci Technol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of a CGM Sensor in Pediatric Subjects With Type 1 Diabetes. Comparison of Three Insertion Sites: Arm, Abdomen, and Gluteus.
Simone Faccioli, Simone Del Favero, Roberto Visentin, Riccardo Bonfanti, Dario Iafusco

J Diabetes Sci Technol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized blood glucose prediction: A hybrid approach using grammatical evolution and physiological models.
Iván Contreras, Silvia Oviedo, Martina Vettoretti, Roberto Visentin, Josep Vehí

PLoS One· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overnight Closed-Loop Control Improves Glycemic Control in a Multicenter Study of Adults With Type 1 Diabetes.
Sue A Brown, Marc D Breton, Stacey M Anderson, Laura Kollar, Patrick Keith-Hynes, Roberto Visentin

J Clin Endocrinol Metab· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis